`Filed: September 20, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC. and AKORN INC.,1
`
`Petitioners,
`
`v.
`
`ALLERGAN, INC.
`
`Patent Owner.
`
`
`
`Case IPR2016-01127 (8,685,930 B2)
`Case IPR2016-01128 (8,629,111 B2)
`Case IPR2016-01129 (8,642,556 B2)
`Case IPR2016-01130 (8,633,162 B2)
`Case IPR2016-01131 (8,648,048 B2)
`Case IPR2016-01132 (9,248,191 B2)
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC.’S
`MANDATORY CHANGE-OF-INFORMATION NOTICES
`
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-00596,
`IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601,
`have respectively been joined with the captioned proceedings. The word-for-word
`identical paper is filed in each proceeding identified in the caption pursuant to the
`Board’s Scheduling Order (Paper 10).
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), the undersigned on behalf of and acting
`
`in a representative capacity for Petitioner Mylan Pharmaceuticals Inc. (“Mylan”),
`
`hereby submits the following mandatory change-of-information notices in
`
`connection with the petitions for inter partes review identified in the caption.
`
`A. Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)) – Unchanged
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2)) – Unchanged
`
`C.
`
`Lead and Back-up Counsel (37 C.F.R. § 42.8(b)(3)) – Revised
`
`Mylan provides the following updated designation of counsel:
`
`Lead Counsel
`Steven W. Parmelee
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Email: sparmelee@wsgr.com
`Back-Up Counsel
`Jad A. Mills
`USPTO Reg. No. 63,344
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2554
`Fax: 206-883-2699
`Email: jmills@wsgr.com
`
`Back-Up Counsel
`Michael T. Rosato
`USPTO Reg. No. 52,182
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2529
`Fax: 206-883-2699
`Email: mrosato@wsgr.com
`Back-Up Counsel
`Wendy L. Devine
`USPTO Reg. No. 61,309
`WILSON SONSINI GOODRICH &
`ROSATI
`One Market Street,
`Spear Tower Floor 33
`San Francisco, CA 94105-1126
`Tel.: 858-350-2321
`Fax: 415-947-2099
`Email: wdevine@wsgr.com
`
`1
`
`
`
`Back-Up Counsel
`Douglas H. Carsten
`USPTO Reg. No. 43,534
`WILSON SONSINI GOODRICH &
`ROSATI
`12235 El Camino Real, Suite 200
`San Diego, CA 92130
`Tel.: 858-350-2305
`Fax: 858-350-2399
`Email: dcarsten@wsgr.com
`
`
`
`
`
`
`Back-Up Counsel
`Richard Torczon
`USPTO Reg. No. 34,448
`WILSON SONSINI GOODRICH &
`ROSATI
`1700 K Street NW, 5th Floor
`Washington, DC 20006
`Tel: 202-973-8811
`Fax: 202-973-8899
`Email: rtorczon@wsgr.com
`Back-Up Counsel
`Brandon M. White
`USPTO Reg. No. 52,354
`PERKINS COIE LLP
`700 13th Street, NW
`Washington, DC 20005
`Tel.: 202-654-6206
`Fax.: 202-654-9681
`Email: bmwhite@perkinscoie.com
`
`D.
`
`Electronic Service
`
`Mylan consents to electronic service by email at the email addresses
`
`provided above.
`
`Dated: September 20, 2017
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
`Steven W. Parmelee
`Reg. No. 31,990
`
`
`
`2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioner Mylan Pharmaceuticals Inc.’s Mandatory Change-of-
`
`th
`Information Notices on this 20
`
`day of September, 2017, on the Patent Owner at
`
`the correspondence address of the Patent Owner as follows:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Morrison Colletti
`Robert M. Oakes
`Jonathan Singer
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Email: IPR13351-0008IP1@fr.com
`Email: IPR13351-0008IP2@fr.com
`Email: IPR13351-0008IP3@fr.com
`Email: IPR13351-0008IP4@fr.com
`Email: IPR13351-0008IP5@fr.com
`Email: IPR13351-0008IP6@fr.com
`Email: PTABInbound@fr.com
`
`Alfonso G. Chan
`Joseph DePumpo
`Christopher L. Evans
`Michael W. Shore
`Shore Chan DePumpo LLP
`901 Main Street, Suite 3300
`Dallas, Texas 75202
`Email: achan@shorechan.com
`Email: jdepumpo@shorechan.com
`Email: cevans@shorechan.com
`Email: mshore@shorechan.com
`
`And on the remaining petitioners as follows:
`
`1
`
`
`
`
`
`Gary Speier
`Mark Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolois, MN 55402
`Email: gspeier@carlsoncaspers.com
`Email: mschuman@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals USA, Inc.
`
`Michael Dzwonczyk
`Azadeh Kokabi
`Travis Ribar
`SUGHRUE MION, PLLC
`2100 Pennsylvania Ave., NW
`Washington, DC 20037
`Email: mdzwonczyk@sughrue.com
`Email: akokabi@sughrue.com
`Email: tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`Dated: September 20, 2017
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
`Steven W. Parmelee
`Reg. No. 31,990
`
`
`
`2
`
`